LMG Life Sciences has named Lowenstein Sandler as a finalist for its 2021 award for “Firm to Watch – Financial & Corporate.”

The organization’s annual awards recognize life sciences practitioners and firms in the United States, Canada, and Europe. Awardees are determined through a rigorous research process involving in-depth firm submissions, practitioner interviews, client feedback, and independent research. 

The awards cover four key practice areas recognized by LMG Life Sciences: regulatory, intellectual property, financial & corporate, and non-IP litigation & enforcement. Winners for each award, along with Impact Cases and Deals and Hall of Fame inductees, will be announced on September 22, 2021, at Essex House in New York.

Lowenstein’s Life Sciences group, chaired by partner Michael J. Lerner, counsels emerging and mature companies, investors, and investment banks in areas ranging from financing and venture capital to intellectual property, FDA regulatory and sales and marketing compliance, mergers and acquisitions, licensing, employment, litigation, antitrust, product liability, and other general commercial and clinical matters relevant to the life sciences industry.

About Lowenstein Sandler LLP
Lowenstein Sandler is a national law firm with over 350 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.

Stephen J. Kimmerling
Director, Marketing Communications
Lowenstein Sandler LLP
T: +1 973.597.6176
E: skimmerling@lowenstein.com